Imidazoline compounds
US6127396A · kind A · utility
4Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1999 |
| Grant date | Oct 3, 2000 |
| Priority date | — |
| Expiry date | Dec 17, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a compound of formula (I): ##STR1## wherein: A represents an optionally substituted benzene ring, PA1 B represents an imidazoline ring of formula (Ia) or (Ib): ##STR2## X represents CR.sup.6, CR.sup.6 R.sup.7, NR.sup.8, SO or SO.sub.2, or oxygen, nitrogen or sulphur, PA1 Y represents a single bond or CH or CH.sub.2, PA1 Z represents a carbon atom or CR.sup.4, PA1 R.sup.1, R.sup.2, R.sup.3, which may be the same or different, each represent hydrogen or alkyl, it being possible for (R.sup.1 and R.sup.4) or (R.sup.2 and R.sup.4) to form cyclopropane, PA1 R.sup.5 represents hydrogen, alkyl or benzyl.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.